5th Annual CEE & CIS Clinical Trials Forum, 18 – 19 April 2012, Vienna
An increasing demand for eligible study patient populations, preparing markets for new medications as well as the need for more cost-efficient clinical development programs are the key drivers for the pharmaceutical industry to perform clinical trials in the CEE and CIS regions. However, these tendencies entail a number of challenges that all industry stakeholders need to face in order to conduct clinically and commercially successful clinical trials. Explore opportunities that CEE & CIS offers, accelerate time to market and achieve cost-efficiency, eliminate existing drawbacks in clinical research, reveal challenges connected to site selection, gain insight into the regulatory aspects and unravel the best practices in patient recruitment and retention.
This 2-days conference is designed to encompass the most pressing issues related to the clinical trials performed in the CEE and CIS region. By participating in our conference you will have the opportunity to:
- Optimize clinical trials to increase your competitiveness
- Explore how to improve timing and feasibility of administration procedures
- Gain insight into the regulatory aspects of the clinical trials in the region
- Understand concerns related to clinical trials from bioethical perspectives
- Overcome hurdles in unification of legislative and normative procedures for the protection of rights of the patients
- Unravel the role of patients organizations in clinical trials in the regions
- Understand the complexity of inclusion of the paediatric population in clinical trials
- Extend your knowledge on experience of diverse countries throughout the region – Ukraine, Russia, Bulgaria, Moldova, Lithuania
More information about this event, you can find on the website www.flemingeurope.com or in the programme of the event .
Eventarchiv
